Title: A Review on Epilepsy

Authors: B.Mayuri, D. Sudheer Kumar, P.Kishore

 DOI: https://dx.doi.org/10.18535/jmscr/v7i3.229

Abstract

Epilepsy is one of the most common neurologic disorders of the brain, affecting about 50 million individuals worldwide, among them 90% patients are from developing countries. It is a universal disorder which affects all age groups.  Genetic factors as well as infection in brain, stroke, tumour and high fever are some of the causes of epilepsy. Each year about 125,000 new epilepsy cases occur; of these, 30 % are younger than age 18 at the time of diagnosis. Prevalence of 3-11/1000 and incidence of 0.2-0.6/1000are observed in India. The hallmarks of seizure generation are hyperexcitability of neurons and hypersynchrony of neural networks. Mechanisms underlying the epilepsy are imbalance between excitatory and inhibitory neurotransmitters. Depending on areas of the brain are involved, epileptic seizures may consist of loss of awareness with tremors, confusion, difficulty in responding; visual or other sensory symptoms are observed. Seizures are classified based on site of origin and symptoms. Benzodiazepines, barbiturates and ion channel modulators are used in the treatment of epilepsy. Treatment should usually be started with single antiepileptic drug. Phenytoin, phenobarbitone, carbamazepine, oxcarbazepine and valproate are usually called first-line drugs. This review discusses epidemiology, aetiology, pathophysiology, classification of epilepsy, symptoms, diagnosis and management of epilepsy.

Keywords: Epilepsy, Seizures, hyperexcitability, anti-epileptic drugs.

References

  1. Suruchi Sharma, Vaishali Dixit, Epilepsy – A Comprehensive Review, International Journal of Pharma Research & Review, 2013, 2(12):61-80.
  2. A. Dekker, Epilepsy: A manual for medical and clinical officers in Africa, 2002.
  3. Hirak Kumar Mukhopadhyay, Chandi Charan Kandar, Sanjay Kumar Das, Lakshmikanta Ghosh, Bijan Kumar Gupta, Epilepsy and its Management: A Review, Journal of PharmaSci Tech 2012; 1(2):20-26.
  4. Hae Won Shin*, Valerie Jewells, Eldad Hadar, Tiffany Fisher and Albert Hinn, Review of Epilepsy - Etiology, Diagnostic Evaluation and Treatment, Int J Neuro rehabilitation Eng 2014, 1:3.
  5. Senthi Amudhan, Gopalkrishna Gururaj, Parthasarathy Satishchandra, Epilepsy in India, I: Epidemiology in public health. Ann Indian Acad Neurol 2015;18:263-277.
  6. J Engel Jr, Epilepsy; Overview, Elsevier 2014.
  7. Johannes D. Lang a, David C. Taylor b, Burkhard S. Kasper, Stress, seizures, and epilepsy: Patient narratives, Epilepsy &Behaviour 80 (2018) 163–172
  8. Emily L. Johnson, Seizures and epilepsy, 0025-7125/18/Elsevier 2018.
  9. Roland D Thijs, Rainer Surges, Terence J O’Brien, Josemir W Sande, Epilepsy inadults, January 24, 2019 ,S0140-6736(18)32596-0.
  10. Mary Anne Koda-Kimble, Lloyd Yee Young, Brian K. Alldredge, Robin L. Corelli, B.Joseph Guglielmo, Wayne A. Kradjan, Bradely B.Williams, Apppied therapeutics a clinical use of drugs 9th
  11. Joseph T.Dipiro, Robert L.Talbert, Gary C. Yee, Gary R.Matzke, Barbara G,Wells, L.MichaelPosey, Pharmacotherapy A pathophysiologic approach, seventh edition.
  12. Solomon L Moshe, Emilio Perucca, Philippe Ryvlin, Torbijorn Tomson, Epilepsy: new advances. Lancet 2015;385:884-98.
  13. Russell J Greene Norman D Harris, Pathology and therapeutics for pharmacy, third edition.
  14. Mrinal Kanti Roy, Dhiman Das, Indian Guidelines on Epilepsy, chapter 116.
  15. J Rugg-gunn and H.B, stapely, Epilepsy 2017.
  16. Gerald liu, Nicole slater, Allen perkins, Epilepsy: treatment options, American family physician july 15, 2017 Volume 96, Number 2.
  17. Ravitas Deshmukh*, Alok S. Thakur and Dhansay Dewangan, Mechanism of action of anticonvulsant drugs: a review, international journal of pharmaceutical research 2017.
  18. W. Sander, Overview of established antiepileptic drugs, chapter 28.
  19. Sushil Tandel, Recent advances in epilepsy, chapter 84.
  20. Sheffali Gulati, Biswaroop Chakrabarty, Dietary therapy in childhood epilepsy, an overview, international journal of epilepsy XXX (2014) 1-9.
  21. Roger walker and C. Whittlesea, Clinical pharmacy and therapeutics 5th

Corresponding Author

Dr P. Kishore

Head, Department of Pharmacy Practice, Care College of Pharmacy, Oglapur (v), Damera (m), Warangal rural, 506006

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Mobile: 7659875277